In the present study, we have established a system where engagement of an adhesion molecule triggers a death signal into cells. L-selectin, which is a well characterized adhesion receptor involved in the initial adhesion between lymphocyte and endothelium, was fused to the intracellular domain of an apoptosis-inducing molecule, Fas. Ligation of the chimeric receptors with a carbohydrate ligand for L-selectin, fucoidin or a mAb that recognizes the lectin domain of L-selectin, induced apoptosis in receptor-expressing cells. However, ligation with an anti-L-selectin mAb reactive with a non-ligand binding site did not induce apoptosis, indicating that stimulation through the lectin domain of L-selectin in the chimeric receptor leads to signal delivery. Upon activation L-selectin shows a unique proteolytic cleavage at the membrane proximal site on the extracellular (EC) domain, of which the significance is also unclear. We found that truncations in the EC domain which abrogate the proteolytic cleavage of L-selectin did not influence induction of apoptosis, suggesting that the cleavage on the EC domain itself is not important for the signaling function of the chimeric receptor. This is the first demonstration that an adhesion signal can be converted to a signal that leads to apoptotic cell death.
Introduction
When leukocytes traffic into the site of inflammation or secondnode homing, since L-selectin is expressed by the majority of leukocytes, and ligands for L-selectin are also expressed ary lymphoid organs, they interact with the endothelium and parenchymal tissues through a variety of adhesion molecules by not only lymph node high endothelial venules but also a few anatomical compartments including the brain white matter (1,2). The current concept is that a sequence of adhesion molecule engagements occurs in order to enhance leukocyte and renal distal tubules (10). Furthermore, although the structure-function relationship of L-selectin has been studied in recruitment. Selectins mediate the early steps in this process, and L-selectin acts as the leukocyte selectin, while E-and detail from a viewpoint of adhesion to ligands, little is known about the structural requirements for signal transduction. P-selectin act as endothelial selectins. L-selectin is a transmembrane glycoprotein composed of several domains includTherefore, in this report, we fused the extracellular (EC) domain of L-selectin with the intracellular (IC) domain of Fas ing the N-terminal lectin-like domain, an epidermal growth factor (EGF)-like domain, short consensus repeats homoto address these issues. Fas is a transmembrane (TM) glycoprotein that mediates the death signal into cells (11) via logous to complement regulatory proteins (SCR), a transmembrane domain and the cytoplasmic domain (3,4). Several a specific intracellular region called the death domain (12) . We chose Fas for construction of the chimeric receptors studies have reported that the lectin domain of L-selectin is involved in the adhesion of lymphocytes to carbohydratebecause the consequence of L-selectin engagement with its ligand can be detected unequivocally. based ligands on the endothelium (5). In line with this notion, the binding of lymphocytes to the high endothelial venules in L-selectin is cleaved from the cell surface at the membrane proximal site upon appropriate cellular activation (13) (14) (15) . peripheral lymph nodes is inhibited by certain types of carbohydrates or anti-L-selectin mAb that recognize the lectinto examine whether the cleavage site of L-selectin is essential L/F-∆15, L/F-∆11, L/F-∆8 and L/F-∆5. For this purpose, a short DNA fragment for the EC domain of L-selectin (nucleotides for signal delivery of the chimeric receptor. We constructed various L-selectin-Fas chimeric receptors with truncation in from 712 to 853 for L/F-∆SCR2, to 1047 for L/F-∆15, to 1059 for L/F-∆11, to 1068 L/F-∆8 or to 1077 for L/F-∆5) was amplified the cleavage site of L-selectin and analyzed their function employing inducibility of apoptosis as a parameter.
by PCR with a pair of primers (see below), and the resultant fragment was digested with KpnI and BamHI. Each fragment was then swapped with the corresponding KpnI-BamHI fragMethods ment in pUCL/F-B. The pair of PCR primers used were 5Ј-CTGGGTACCATGACCTGT-3Ј containing a KpnI site and
AAAGGATCCCTTGATCTTTGAGAAACT-3Ј(L/F-∆5), each containing a BamHI site. constructions, we used the plasmid pRM7 containing rat L-selectin cDNA (17) and pUC119 vector containing the full Finally, each fragment encoding the chimeric receptor was released from each plasmid by XbaI digestion and inserted length human Fas cDNA (pUCfas) as PCR templates or digestion with restriction endonucleases.
into the XbaI site of a mammalian expression vector pEF-BOS (18) . In addition to the above plasmids, we constructed Construction of a recombinant plasmid encoding the L/F-S chimeric protein was performed as follows. A DNA fragment an expression plasmid encoding a full length wild-type rat L-selectin (LEC). To construct LEC, pRM7 was first digested encoding the EC and TM domains of L-selectin (nucleotides 1-1156) was amplified by PCR. The PCR primers used were with EcoRI. We then inserted a fragment into pEF-BOS. The above prepared plasmids were individually confirmed by 5Ј-TTTGAATTCCTGAGTGCAGCA-3Ј including an EcoRI site at the 5Ј end and 5Ј-TTTGAATTCCTTTCTCTTCACCCAAATsequencing the PCR fragment and junction regions. GATAAATGCTGCCAGCCC-3Ј bearing an EcoRI site at the 5Ј Cells terminus directly downstream of which follows a sequence encoding a part of the L-selectin TM domain. We subcloned A human leukemia cell line, Jurkat (ATCC, Rockville, MD), was maintained in RPMI 1640 containing 10% FCS, 10 mM the PCR fragment to the EcoRI site of the pUC119 vector (pUC119LEC-TM). A fragment encoding the IC domain of Fas HEPES, 2 mM L-glutamine, 1 mM sodium pyruvate, 1% (v/v) 100ϫnon-essential amino acids, 100 U/ml penicillin and (nucleotides 760-1427) was amplified by PCR. The PCR primers used were 5Ј-TTCCCGGGAGTACAGAAAACATGC-100 µg/ml streptomycin (complete medium).
To obtain clones that express L-selectin or L-selectin-AGA-3Ј containing a SmaI site at the 5Ј terminus and 5Ј-TACTTAGCATGCCACTGCATT-3Ј containing a SphI site. The Fas fusion protein, the recombinant plasmid, together with pSV2neo carrying the neomycin resistance gene, were introresulting fragment was subcloned between the SmaI and the SphI sites of the pUC119 vector to construct pUCfas(760-duced into Jurkat cells by electroporation. Transfectants were selected in the complete medium containing 1 mg/ml geneticin 1427 Chester, PA), and analyzed by flow cytometry on an Epics XL flow cytometer (Coulter Electronics, Hialeah, FL). HRL2 The resultant BamHI-SphI fragment was inserted into pUC119 to obtain pUCfas(700-1427). Finally, the EcoRI-BamHI fragrecognizes the second SCR domain of L-selectin, since it reacts with intact L-selectin but not with L-selectin lacking ment of L-selectin cDNA was ligated with pUCfas(700-1427). We designated this plasmid as pUCL/F-B.
this domain (Figs 1 and 2, L/F-∆SCR2). Another anti-rat-L-selectin mAb, HRL3, on the other hand, reacts with this To construct a recombinant plasmid for the L/F-F chimeric protein, PCR was performed to obtain a short DNA fragment mutant by recognizing the lectin domain (19) . Binding of the L-selectin ligand, fucoidin, was also evaluated (nucleotides 712-1093), which included the membrane proximal 30 amino acids of L-selectin. The PCR primers used by flow cytometry. For this purpose, 1ϫ10 5 cells were incubated for 15 min at 4°C with 0-100 µg/ml of fucoidin (Sigma) were 5Ј-CTGGGTACCATGACCTGT-3Ј containing a KpnI site, and 5Ј-AAAGGATCCGTTATAGTCGCCTTCCTT-3Ј containing or 100 µg/ml mannan (Sigma) dissolved in PBS containing 1 mM Mg 2ϩ and 1 mM Ca 2ϩ . We then added mAb HRL3 a BamHI site. The resultant fragment was digested with KpnI and BamHI, and transferred to pUCL/F-B at KpnI-BamHI sites.
(5 µg/ml, final concentration) that blocks the binding of fucoidin. Subsequently, the cells were washed, stained with We also constructed recombinant plasmids for L/F-∆SCR2, containing 10 µg/ml mAb HRL2, HRL3 (19) , normal hamster IgG (Cappel), fucoidin or mannan. Cell viability was assessed by staining with propidium iodide (PI) (Molecular Probes, Induction of endoproteolytic cleavage of L-selectin Eugene, OR) and Hoechst 33342 (Molecular Probes). In brief, cells pre-incubated with the indicated antibody or reagent for
were stained with 10 µg/ml PI and 10 µg/ml transfectants were incubated at 37°C for 15 min in PBS Hoechst 33342 for 10 min at 37°C. Subsequently, viable, containing 50 ng/ml phorbol myristate acetate (PMA) (19) . apoptotic or necrotic cells were differentiated under a fluores-
The cells were then incubated with HRL2 followed by FITCcence microscope according to their PI-and Hoechst 33342-goat anti-hamster IgG to determine the extent of shedding or specific staining patterns. Due to the differential membrane proteolytic cleavage of L-selectin or L-selectin-Fas fusion permeability characteristics, PI stained the nucleus of apopprotein by flow cytometry. totic as well as necrotic cells, whereas Hoechst dye stained every cell. Therefore, Hoechst-stained cells with intact nuclei Results were considered viable, whereas those with condensed or fragmented nuclei represented apoptotic cells. PI-stained Construction and expression of L-selectin-Fas chimeric cells with non-fragmented nuclei were considered to be receptors necrotic cells.
We constructed three plasmids encoding chimeras of rat Cell death was also confirmed by detecting DNA fragmenta-L-selectin and human Fas (Fig. 2) . One of these plasmids, tion. For this purpose, genomic DNA was obtained from cells named L/F-S, contained the entire EC and TM domains of treated with HRL2, HRL3, fucoidin, normal hamster IgG or L-selectin fused to the IC domain of Fas. On the other hand, 1 µg/ml anti-human Fas mAb 2D1 (20) using the method of L/F-F contained the entire EC domain of L-selectin fused to Sellins and Cohen (21) with some modification. Briefly, 5ϫ10 5 the TM and IC domains of Fas. A third plasmid, L/F-B, was cells were lysed with a lysis buffer (10 mM Tris-HCl pH 7.4, very similar to L/F-F except that it lacked the membrane 10 mM EDTA and 0.5% Triton X-100) followed by incubation proximal 30 amino acids of the L-selectin EC domain conwith 400 µg/ml of RNase A and proteinase K. The supernatant taining the proteolytic cleavage site (22) . L-selectin is rapidly was harvested and DNA was precipitated in 50% isopropyl down-regulated from the cell surface through an inducible alcohol with 0.4 M NaCl and subjected to 1.5% agarose proteolytic cleavage (23), although its significance in intergel electrophoresis. Finally, the gel was stained with ethidium action with ligands is unknown at present. In the next step, bromide.
we transfected these three plasmids or the LEC plasmid encoding the wild-type L-selectin into Jurkat cells and Fluorescence confocal microscopy Similarly, the LEC clone expressed comparable levels of wildtype L-selectin.
Induction of apoptosis in cells expressing chimeric L-selectinFas receptors
To examine whether the death signal can be transduced by stimulating the chimeric receptors, we treated cells with fucoidin which binds to the lectin domain of L-selectin (24) . Nuclear condensation and fragmentation was observed soon after treatment with fucoidin, followed by cell death within 7 h (Fig. 4A) . In contrast, no cell death was induced by mannan, which does not bind to L-selectin. The fucoidin-induced cell death was readily induced in high expressors of L/F-S and L/ F-F containing the TM domain derived from L-selectin and Fas respectively. However, cell death was less readily induced by fucoidin in low expressors ( Table 1 ), suggesting that the induction of apoptosis depends on the expression level of the chimeric receptors and that the derivation of the TM domain of the chimeric receptors does not influence their signal transducing abilities. Fucoidin treatment did not influence the viability of cells expressing the wild-type L-selectin (LEC). To confirm that the fucoidin-induced cell death was due to apoptosis, we isolated the genomic DNA, 2 or 4 h after fucoidin treatment, and examined DNA fragmentation as an indicator of apoptosis (Fig. 4B) . Since parental Jurkat cells are sensitive to the anti-Fas antibody-induced apoptosis (20, 25) , cells treated with anti-human Fas mAb were used as positive control (Fig. 4B, lane 3) . Similar to treatment with anti-Fas, a marked DNA fragmentation, a hallmark of apoptosis, was observed within 2 h of incubation with fucoidin in L/F-S clones (Fig. 4B, lanes 10 and 11) , confirming that fucoidin-induced cell death was due to apoptosis.
Interestingly, all L/F-B clones expressing the chimeric (Table 1 ) and no DNA fragmentation was observed (Fig. 4B , chimeric receptors, we examined fucoidin binding to each 
a Cells (5ϫ10 4 ) were treated with HRL2, HRL3, normal hamster IgG, fucoidin or mannan. Percentage of apoptotic cells induced by mannan is subtracted from that by fucoidin, and expressed as follows. Values 0-10%, Ϫ; 30-50%, ϩ; 50-80%, ϩϩ. For HRL2 or HRL3, percentage of apoptotic cells induced by normal hamster IgG is subtracted. The summarized data of at least three experiments is shown.
b Cells were incubated at 37°C for 15 min in PBS containing 50 ng/ml PMA and stained with HRL2 followed by FITC-goat anti-hamster IgG. The disappearance of L-selectin from the surface of cells was evaluated by flow cytometry. transfectant. Since we had difficulties in labeling fucoidin with cells after fucoidin treatment was observed dose-dependently and complete at 50 µg/ml of fucoidin. These results suggest fluorochrome, we used the competition binding assay and examined if the binding of mAb HRL3 that recognizes the lectin that the chimeric receptors bind fucoidin as efficiently as the wild-type L-selectin. The inhibition by fucoidin was completely domain of L-selectin is interfered with by fucoidin which also binds to the lectin domain (19) . As shown in Fig. 5 , fucoidin abrogated by treatment with EDTA (data not shown) corroborating with its selective binding to the Ca 2ϩ -dependent lectin interfered with HRL3 binding in a dose-dependent manner in contrast to mannan, and complete inhibition occurred at 50 µg/ domain of L-selectin (24, 26) . In L/F-B, which is resistant to fucoidin-induced apoptosis, ml of fucoidin in LEC, L/F-S and L/F/F clones. With the latter two clones, expression of the chimeric receptors was weaker than fucoidin inhibited the binding of HRL3, albeit less prominently, indicating that fucoidin binds to this clone but less effectively the LEC clones and the shift of the peak fluorescence intensity was hence less obvious. However, the disappearance of bright compared with other clones.
Induction of apoptosis by cross-linking of L-selectin with anti-L-selectin antibody To examine whether stimulation of the lectin domain of L-selectin is crucial for induction of cell death, we used anti-L-selectin antibodies HRL2 and HRL3, that specifically bind to the non-ligand binding SCR2 domain and the lectin domain respectively. Treatment with HRL3, but not HRL2, resulted in apoptosis of L/F-S and L/F-F transfectants within 24 h (Table  1) . These findings were confirmed by results of DNA fragmentation studies showing a typical DNA ladder pattern in HRL3-treated L/F-S cells (Fig. 4B, lanes 8 and 9) but not in those treated with HRL2 (lanes 6 and 7). Similar results were obtained with L/F-S clones (data not shown). No cell death was induced even after further cross-linking of the chimeric protein with HRL2 or anti-hamster Ig second antibody (data not shown). These results indicate that the death signal is induced by stimulation through the lectin domain and not by mere cross-linking of L-selectin-Fas fusion protein. As was noted with fucoidin treatment, cell death was hardly induced in the L/F-B transfectant when treated with HRL3, suggesting that the membrane proximal 30 amino acids of L-selectin, which are deleted in the L/F-B construct, may contribute significantly to function of the chimeric receptor. Fas-induced cell death requires oligomerization of Fas molecules on the cell surface (27) . To examine if the differential induction of apoptosis is due to differences in the crosslinking ability of HRL2 and HRL3, cells were incubated with either FITC-labeled HRL2 or FITC-HRL3, and the extent of antibody-induced clustering of the chimeric receptors was both antibodies induced marked aggregation and capping of the chimeric or wild-type L-selectin, with a slightly better cross-linking ability of HRL2 compared with HRL3. These results also support the above-mentioned notion that ligation On the other hand, apoptosis occurred in L/F-∆5, L/F-∆8, L/ of or stimulation through the ligand binding domain is import-F-∆11 and L/F-∆15 clones when they were treated with fucoidin ant and that mere cross-linking of the EC domain is insufficient or HRL3 (Table 2 ). These results suggest that the cleavage for signal transduction via the L-selectin-Fas chimeric of L-selectin is not directly related to the function of the receptors.
chimeric receptor in apoptosis. Induction of apoptosis via L-selectin-Fas chimeric receptors bearing deletions in the membrane proximal region of the Discussion EC domain As shown in Table 1, HRL3 resulted in negligible or no cell In this study, we demonstrated that chimeric receptors consisting of the EC domain of L-selectin and the IC domain death of L/F-B transfectants, although it induced prominent clustering of the chimeric receptors (Fig. 6) . The L/F-B lacks derived from Fas induced apoptosis into cells. We showed that stimulation through the carbohydrate-ligand binding lectin the membrane proximal 30 amino acids, 50% of which represents the proteolytic cleavage site of L-selectin while domain is crucial and that the derivation of the TM domain of the chimeric receptors, be it from L-selectin or Fas, does not the remaining 15 amino acids represent a part of the SCR2 region neighboring the cleavage site. As we expected, L/F-B affect the function of the chimeric receptor. We also showed that abrogation of a proteolytic cleavage potential does not was not shed from the cell surface by treatment with PMA (Table 1) . To examine whether proteolytic cleavage is related influence apoptosis inducibility, indicating that the cleavage of the EC domain plays little or no role in the function of the to the function of the chimeric receptors, and which of the regions contribute significantly to the inducibility of apoptosis, chimeric receptor.
Since the association of cell surface L-selectin to its ligand we constructed several L-selectin-Fas chimeric receptors lacking five to 15 amino acids in the proteolytic cleavage site is not so strong as seen with other adhesion receptors, L-selectin-mediated cell adhesion is often not readily of the L-selectin ( Fig. 7A ; L/F-∆5, L/F-∆8, L/F-∆11 and L/F-∆15) and expressed them individually in Jurkat cells (Fig. detected. Therefore, we attempted to establish a system where engagement of L-selectin on the cell surface can be 7B). Treatment with PMA resulted in shedding of the chimeric L-selectin from the cell surface of L/F-∆5 transfectant, but not equivocally detected. We showed that the death signal is induced when the chimeric receptors were stimulated by a of the L/F-∆8, L/F-∆11 and L/F-∆15 transfectants (Table 2) . 
a Values 0-10%, Ϫ; 30-50%, ϩ; 50-80%, ϩϩ; 80-100%, ϩϩϩ. Percentage of apoptotic cells induced by each reagents or antibody was evaluated as shown in Table 1 . The summarized data of at least three experiments is shown.
b Cleavage of L-selectin from the surface of cells was evaluated as shown in Table 1. ligand of L-selectin, fucoidin, or by a mAb HRL3 against the receptor family was fused to the IC domain of Fas (28), a cytotoxic signal was induced by CD40 ligand gp39 but not lectin domain. Interestingly, mAb HRL2 that recognizes the SCR2 domain was unable to induced a death signal (Table  with an anti-CD40 mAb recognizing an epitope distinct from that bound by gp39. These results indicate that appropriate 1), although the extent of cross-linking of L-selectin did not appear to be different between these two antibodies as receptor clustering or cross-linking through the specific epitope is critical for the generation of a transmembrane signal assessed by confocal microscopy on the surface of mAbtreated cells (Fig. 6) . The observation that HRL2 mAb failed by cell surface receptors. Various truncations made on the EC domain of L-selectin to induce apoptosis even after cross-linking with a secondary (data not shown) suggested that mere receptor oligomerizchimeras in our study showed that cleavage of L-selectin is not essential for apoptosis inducibility of the chimeric receptors. ation does not necessarily result in induction of apoptosis. Similar to our results, in studies where the EC domain of a B
Results of the initial experiments where we removed 30 amino acids near the membrane proximal site containing the cell-associated CD40 belonging to the tumor necrosis factor proteolytic cleavage site indicated that abrogation of the for induction of apoptosis via the L-selectin-Fas chimeric receptors. The use of chimeric receptors as demonstrated in cleavage on the EC domain may result in interruption of the function of the chimeric receptor. However, in subsequent our study will help analyze the structural requirement of the EC domain of other adhesion molecules necessary for their experiments where we removed only a cleavage site consisting of 15 amino acids residues, we demonstrated that the signal delivery. Furthermore, application of cells expressing the L-selectin-Fas chimeric receptor to in vivo studies will proteolytic cleavage of L-selectin is not significantly related to induction of apoptosis and that deletion of 15 amino acids provide an interesting possibility which will allow the true physiological function of L-selectin to be analyzed in situ, in the SCR2 domain adjacent to the cleavage site might be responsible for abrogation of apoptosis. Since modulation of although it needs to be verified if apoptosis can be induced in vivo upon engagement of the chimeric receptor with the SCR region has been reported to affect the structure of the ligand binding domain (29) and, hence, may alter ligand its ligand. binding, we examined the ability of the chimeric receptors lacking 30 amino acids to bind fucoidin and found that these
